Swiss dental startup vVardis shares slide 7% in NYSE debut as tech selloff roils IPO market
Story summaryvVardis had sold 9.7 million shares at $18 apiece in its IPO, well below its targeted range of $21 to $24 per share.
Read at New York PostOpens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.